menu
    • menu

    Company profile for Azitra

    NEW Drugs in Dev: 7
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A clinical stage medical dermatology company that leverages its extensive knowledge of proteomics, genetic engineering and the skin microbiome to create and develop novel products for the treatment of skin conditions and diseases. Broad product opportunities for developing novel antimicrobials and other therapeutics. Azitra Inc. is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about...
    A clinical stage medical dermatology company that leverages its extensive knowledge of proteomics, genetic engineering and the skin microbiome to create and develop novel products for the treatment of skin conditions and diseases. Broad product opportunities for developing novel antimicrobials and other therapeutics. Azitra Inc. is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AzitraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Farmington Avenue Farmington, CT 06032
    Telephone
    Telephone
    860.679.4292
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://azitrainc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/azitra-inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/azitraraleigh

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Azitra Reveals Q1 2026 Results And Business Updates
    Azitra Reveals Q1 2026 Results And Business Updates

    13 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-inc-announces-q1-2026-results-and-provides-business-updates-302770153.html

    PR NEWSWIRE
    13 May 2026
    Share Share
    Azitra Announces New U.S. Patent Protecting ATR-12 Program
    Azitra Announces New U.S. Patent Protecting ATR-12 Program

    06 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-inc-announces-new-us-patent-protecting-atr-12-program-302763513.html

    PR NEWSWIRE
    06 May 2026
    Share Share
    Azitra to Present ATR-01 Ichthyosis Vulgaris Data at ASGCT 2026
    Azitra to Present ATR-01 Ichthyosis Vulgaris Data at ASGCT 2026

    28 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-inc-announces-poster-presentation-at-asgct-2026-highlighting-atr-01-program-for-ichthyosis-vulgaris-302755095.html

    PR NEWSWIRE
    28 Apr 2026
    Share Share
    Azitra Prices Private Placement Up To $31.4 M
    Azitra Prices Private Placement Up To $31.4 M

    19 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-announces-pricing-of-private-placement-financing-of-up-to-approximately-10-5-million-with-up-to-an-additional-approximately-20-9-million-302719064.html

    PR NEWSWIRE
    19 Mar 2026
    Share Share
    Azitra Cancels 2026 Stockholders Meeting
    Azitra Cancels 2026 Stockholders Meeting

    06 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-inc-announces-cancellation-of-2026-special-meeting-of-stockholders-302705612.html

    PR NEWSWIRE
    06 Mar 2026
    Share Share
    Azitra Announces Full Year 2025 Results and Business Updates
    Azitra Announces Full Year 2025 Results and Business Updates

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-inc-announces-full-year-2025-results-and-provides-business-updates-302699417.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search